Latest NEA Management Company, LLC Stock Portfolio

NEA Management Company, LLC Performance:

2025 Q4: 16.07%YTD: 78.6%2024: 1.12%

Performance for 2025 Q4 is 16.07%, and YTD is 78.6%, and 2024 is 1.12%.

About NEA Management Company, LLC and 13F Hedge Fund Stock Holdings

NEA Management Company, LLC is a hedge fund based in Chevy Chase, MD. On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, NEA Management Company, LLC reported an equity portfolio of $2 Billions as of 31 Dec, 2025.

The top stock holdings of NEA Management Company, LLC are CELC, RYTM, ACLX. The fund has invested 18% of it's portfolio in CELCUITY INC. and 15.9% of portfolio in RHYTHM PHARMACEUTICALS, INC.

The fund managers got completely rid off VERONA PHARMA PLC (VRNA), NEUEHEALTH INC (BHG) and OMADA HEALTH INC stocks. NEA Management Company, LLC opened new stock positions in LEONABIO, INC. (ATHA). The fund showed a lot of confidence in some stocks as they added substantially to CELCUITY INC. (CELC), X4 PHARMACEUTICALS, INC. (XFOR) and ZENAS BIOPHARMA, INC..

NEA Management Company, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that NEA Management Company, LLC made a return of 16.07% in the last quarter. In trailing 12 months, it's portfolio return was 78.6%.

Performance
S&P 500

New Buys

Ticker	$ Bought
leonabio, inc.	3,515,490

New stocks bought by NEA Management Company, LLC

Additions

Ticker	% Inc.
celcuity inc.	64.88
x4 pharmaceuticals, inc.	44.77
zenas biopharma, inc.	28.88

Additions to existing portfolio by NEA Management Company, LLC

Reductions

None of the existing positions were reduced by NEA Management Company, LLC

Sold off

Ticker	$ Sold
neuehealth inc	-18,188,500
verona pharma plc	-240,417,000
omada health inc	-8,050,580

NEA Management Company, LLC got rid off the above stocks

Sector Distribution

NEA Management Company, LLC has about 82% of it's holdings in Healthcare sector.

Sector	%
Healthcare	82
Others	13.2
Consumer Defensive	4.8

Market Cap. Distribution

NEA Management Company, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	46.8
SMALL-CAP	36.4
UNALLOCATED	13.2
MICRO-CAP	2.9

Stocks belong to which Index?

About 79.3% of the stocks held by NEA Management Company, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	79.3
Others	20.7

Top 5 Winners (%)		%
GLUE	monte rosa therapeutics, inc.	111.6 %
	mbx biosciences, inc.	80.2 %
SVRA	savara, inc.	68.9 %
CELC	celcuity inc.	68.2 %
MRKR	marker therapeutics, inc.	66.9 %

Top 5 Winners ($)		$
CELC	celcuity inc.	143.0 M
GLUE	monte rosa therapeutics, inc.	63.6 M
SVRA	savara, inc.	60.2 M
	mbx biosciences, inc.	50.7 M
TRVI	trevi therapeutics, inc.	44.6 M

Top 5 Losers (%)		%
	korro bio, inc.	-83.3 %
COUR	coursera, inc.	-37.1 %
BDTX	black diamond therapeutics, inc.	-35.9 %
SYBX	synlogic, inc.	-32.9 %
ORIC	oric pharmaceuticals, inc.	-31.8 %

Top 5 Losers ($)		$
COUR	coursera, inc.	-56.0 M
ACLX	arcellx, inc.	-51.5 M
	korro bio, inc.	-43.5 M
ORIC	oric pharmaceuticals, inc.	-15.7 M
CRSP	crispr therapeutics ag	-13.1 M

NEA Management Company, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of NEA Management Company, LLC

NEA Management Company, LLC has 27 stocks in it's portfolio. About 86.5% of the portfolio is in top 10 stocks. COUR proved to be the most loss making stock for the portfolio. CELC was the most profitable stock for NEA Management Company, LLC last quarter.

Last Reported on: 17 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACLX	arcellx, inc.	10.12	3,045,260	198,551,000	unchanged	0.00

ATHA	leonabio, inc.	0.18	464,398	3,515,490	new

AUPH	aurinia pharmaceuticals, inc.	3.23	3,969,830	63,318,900	unchanged	0.00

BDTX	black diamond therapeutics, inc.	0.55	4,448,760	10,810,500	unchanged	0.00

BHG	neuehealth inc	0.00	0.00	0.00	sold off	-100

CELC	celcuity inc.	17.98	3,535,560	352,637,000	added	64.88

COUR	coursera, inc.	4.83	12,867,800	94,706,800	unchanged	0.00

CRSP	crispr therapeutics ag	2.83	1,058,570	55,511,400	unchanged	0.00

CSBR	champions oncology, inc.	0.60	1,713,720	11,841,800	unchanged	0.00

CVRX	cvrx, inc.	0.73	2,026,080	14,385,200	unchanged	0.00

GLUE	monte rosa therapeutics, inc.	6.15	7,692,300	120,615,000	unchanged	0.00

GOSS	gossamer bio, inc.	2.86	18,093,000	56,088,400	unchanged	0.00

IKNA	imagenebio, inc.	0.02	50,005	345,035	unchanged	0.00

IVA	inventiva sa	0.35	1,462,590	6,801,020	unchanged	0.00

MRKR	marker therapeutics, inc.	0.12	1,625,680	2,422,260	unchanged	0.00

NKTX	nkarta, inc.	0.34	3,568,780	6,602,240	unchanged	0.00

ORIC	oric pharmaceuticals, inc.	1.72	4,118,620	33,690,300	unchanged	0.00

PHAT	phathom pharmaceauticals, inc.	1.66	1,960,170	32,519,200	unchanged	0.00

RYTM	rhythm pharmaceuticals, inc.	15.88	2,909,960	311,482,000	unchanged	0.00

SNTI	senti biosciences, inc.	0.20	3,775,620	3,926,640	unchanged	0.00